Clinical Data Archives - Carenity Pro

Carenity, part of the EvidentIQ Group, announces change in leadership

Léa Blaszczynski — Thu, 01 Jun 2023 08:22:21 +0000

Carenity, a prominent patient-centric company and member of the EvidentIQ Group, announces a change in its leadership.

Michael Chekroun, founder of Carenity and outgoing President, will be stepping down from his role as of today. Lise Radoszycki, former COO, will be taking the helm as the new President, bringing extensive experience and expertise that will propel the company into its next phase of expansion and development.

Michael Chekroun has played for the past 12 years a central role in building and shaping the company, leading it through successful initiatives, strategic partnerships, and most of all creating a sustainable and innovative model that allows patients to share their experiences while making medical knowledge advance. Michael has chosen to step down, two years after selling his company to EvidentIQ, to focus on new entrepreneurial projects.

Lise Radoszycki, with a proven track record of success, brings 8 years of experience and a strong vision for Carenity’s future. With a background in data science and biostatistics engineering and having previously occupied crucial leadership roles within the organization, Lise has demonstrated a remarkable ability to effectively implement strategic initiatives and nurture innovation. With her profound industry insights, and exceptional leadership capabilities, Lise is poised to guide Carenity on its continued growth trajectory and ensure that the needs and expectations of patients are better considered by health actors.

Commenting on the leadership transition, Michael said “I am leaving with gratitude and a sense of achievement. I have the conviction that Lise and the team will pursue Carenity’s mission with determination and passion.”

Lise expressed her enthusiasm about her new role, stating “I am very honored to be given this opportunity, because this company and its patient-centered values are very important to me. I am committed to driving Carenity’s growth by prioritizing the patients’ needs in all my decisions, as well as ensuring our clients’ satisfaction by conducting sophisticated RWE studies.”

The board of investors and the entire EvidentIQ team extend their sincere appreciation to Michael for his exceptional leadership, dedication, and numerous contributions. They are confident that Lise will build upon the strong foundation laid by Michael and drive Carenity to even greater success.

About Carenity

Carenity, part of the EvidentIQ Group, is a leading digital CRO specialized in direct-to-patient studies conducted via its digital social platform supporting +500k patients and caregivers worldwide across 1,200+ illnesses.
Since 2011, Carenity’s mission has been to empower patients so they can share their experience with other patients, find information, manage their illness, and generate real-world online research studies.
With its innovative platform, Carenity – the Patient Insights Company – delivers timely and compliant direct-to-patient research solutions to the life sciences industry that fuel the development of better medicines and health services.

Source: (PresseBox Carenity, part of the EvidentIQ Group, announces change in leadership) (Paris, France, 06/01/2023)

The post Carenity, part of the EvidentIQ Group, announces change in leadership appeared first on Carenity Pro.

Innovative Real-World-Evidence generation to efficiently combine digital biomarkers and self-reported outcomes

Léa Blaszczynski — Wed, 18 May 2022 08:53:17 +0000

How to leverage data linkage to get better outcomes?

EvidentIQ, a leading clinical data science group, announced its partnership with Feel Therapeutics, a digital therapeutics US-based company. The alliance between these two visionaries of tech has resulted in the building of unique end-to-end solutions to link data and digitize clinical trials through a seamless patient journey supported by direct access to patients, best-in-class technologies and in-house data science expertise.

What is Real-World Evidence and the different sources of Real-World Data?
How to collect real-time physiological data 24/7 to monitor emotions, physical activity, and sleep quality: the example of Feel Therapeutics Data Monitoring and Digital Endpoint Discovery Platform
How to efficiently collect self-reported outcomes?
How to combine these two innovative data sources?

On May 12th our data linkage webinar took place. We showed you how innovative Real-World-Evidence generation can help to efficiently combine digital biomarkers and self-reported outcomes.

Access the replay! We will walk you through the new data linkage thanks to this partnership, combining best-in-class technologies and expertise of EvidentIQ and Feel Therapeutics.

Access the replay

Download the presentation

The post Innovative Real-World-Evidence generation to efficiently combine digital biomarkers and self-reported outcomes appeared first on Carenity Pro.

Implementing a DCT – Decentralized Clinical Trial: the road to success

Léa Blaszczynski — Wed, 16 Mar 2022 11:18:40 +0000

How to leverage both patient centricity and digital innovation in clinical research?

Over the past years, clinical research has entered a new area with an increasing adoption of DCT – Decentralized Clinical trial – fully or hybrid, which has been accelerated by the COVID-19 pandemic. Thanks to digital health solutions and the recent evolution of regulatory framework, DCT means a promising future for clinical trials. However, there are still challenges to define a DCT strategy for a clinical trials.

What are the key success factors to implement a DCT? How to assess what protocol evaluations can be off-site? What are expectations from regulators and IRB/Ethics Committees? How to leverage patient insights to build adapted and patient-centric DCT? How to select the adequate technology components?

On March 10th our Decentralized Clinical Trial webinar took place. We showed you how to leverage both patient centricity and digital innovation in clinical research.

Access the replay! We will walk you through the key steps to implement successfully a DCT and share EvidentIQ’s expertise and state-of-the-art technologies to support your DCT approach.

Access the replay

The post Implementing a DCT – Decentralized Clinical Trial: the road to success appeared first on Carenity Pro.

Webinar – Implementing a DCT – Decentralized Clinical Trial: the road to success – 10th March 2022

Léa Blaszczynski — Fri, 18 Feb 2022 18:27:57 +0000

How to leverage both patient centricity and digital innovation in clinical research?

Over the past years, clinical research has entered a new area with an increasing adoption of DCT – Decentralized Clinical trial – fully or hybrid, which has been accelerated by the COVID-19 pandemic. Thanks to digital health solutions and the recent evolution of regulatory framework, DCT means a promising future for clinical trials. However, there are still challenges to define a DCT strategy for clinical trials.

Come join us, we will walk you through the key steps to successfully implement a DCT and share EvidentIQ’s expertise and state-of-the-art technologies to support your DCT approach.

Don’t hesitate, register now!

The post Webinar – Implementing a DCT – Decentralized Clinical Trial: the road to success – 10th March 2022 appeared first on Carenity Pro.